Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 Oct 3;18(10):e0291757. doi: 10.1371/journal.pone.0291757

MRI overestimates articular cartilage thickness and volume compared to synchrotron radiation phase-contrast imaging

Suranjan Bairagi 1, Mohammad-Amin Abdollahifar 1, Oghenevwogaga J Atake 1, William Dust 2, Sheldon Wiebe 3, George Belev 4, L Dean Chapman 1, M Adam Webb 4, Ning Zhu 4, David M L Cooper 1, B Frank Eames 1,*
Editor: Zhentian Wang5
PMCID: PMC10547194  PMID: 37788257

Abstract

Accurate evaluation of morphological changes in articular cartilage are necessary for early detection of osteoarthritis (OA). 3T magnetic resonance imaging (MRI) has highly sensitive contrast resolution and is widely used clinically to detect OA. However, synchrotron radiation phase-contrast imaging computed tomography (SR-PCI) can also provide contrast to tissue interfaces that do not have sufficient absorption differences, with the added benefit of very high spatial resolution. Here, MRI was compared with SR-PCI for quantitative evaluation of human articular cartilage. Medial tibial condyles were harvested from non-OA donors and from OA patients receiving knee replacement surgery. Both imaging methods revealed that average cartilage thickness and cartilage volume were significantly reduced in the OA group, compared to the non-OA group. When comparing modalities, the superior resolution of SR-PCI enabled more precise mapping of the cartilage surface relative to MRI. As a result, MRI showed significantly higher average cartilage thickness and cartilage volume, compared to SR-PCI. These data highlight the potential for high-resolution imaging of articular cartilage using SR-PCI as a solution for early OA diagnosis. Recognizing current limitations of using a synchrotron for clinical imaging, we discuss its nascent utility for preclinical models, particularly longitudinal studies of live animal models of OA.

Introduction

The most common cartilage disease is osteoarthritis (OA), where articular cartilage of the joint is destroyed either as a normal aging process or as a secondary disease from trauma [1, 2]. Given associated pain, swelling, and joint dysfunction, OA dramatically affects work and life productivity. Although destruction of articular cartilage is a gradual process, OA is hard to detect early, delaying diagnosis until significant patient symptoms exist and irreversible joint damage has occurred [1, 2]. As a result, most OA diagnoses are severe cases and are treated by replacing the joint surfaces with prosthetic components. The ability to accurately assess structural changes in articular cartilage would enable early detection of OA, opening up new avenues of treatment that might prevent disease progression [1, 35].

Common clinical techniques to image articular cartilage make OA challenging to diagnose [1, 69]. While standard X-ray radiographs are the most common type of imaging in clinics, cartilage is not visible with this modality, so one is left assessing joint space narrowing as a surrogate for cartilage loss. Clearly, standard X-rays cannot detect early or minor changes to articular cartilage [1012].

Currently, the preferred clinical modality to image cartilage is magnetic resonance imaging (MRI) [1316]. MRI uses a large magnetic field and radio waves to coordinate the nuclear magnetization of hydrogen atoms [14]. The contrast in MRI is based on the differences of hydrogen (protons) in the various tissues, such as cartilage, compared to surrounding tissues [15]. Accordingly, several MRI protocols for imaging articular cartilage semi-quantitatively and quantitatively have been developed in clinical research studies, each having strengths and weaknesses [1720]. Two common clinically-relevant parameters, average cartilage thickness and overall cartilage volume, can be measured from MRI datasets using a fully automatic method for subregional segmentation of articular cartilage [21, 22]. For example, MRI datasets were used to determine the extent to which anatomical force application explained variation in femoral and tibial cartilage thickness and volume in knee OA [23].

Although higher strength magnets can increase MRI resolution by detecting signals in smaller voxel sizes, 3 Tesla (3T) scanners are the preferred strength in most musculoskeletal imaging clinics [24]. 3T MRI has limited resolution to visualize details of cartilage morphology [2527]. For example, knee OA MRI studies showed an overall mean error of ±0.2–0.3 mm in cartilage thickness, an inaccuracy that could stand in the way of early OA diagnosis [28, 29]. Therefore, to achieve a more accurate diagnosis of morphological changes in articular cartilage, more sensitive imaging technologies should be developed [30, 31].

One unique imaging method is synchrotron radiation phase-contrast imaging computed tomography (SR-PCI). In a synchrotron, high-energy electromagnetic radiation is emitted by electrons moving at speeds close to that of light [32, 33]. SR enables high-resolution imaging because it has high photon flux, stable sources, and an energy density 1000 times higher than conventional X-ray absorption imaging [34, 35]. Some synchrotron imaging techniques take advantage of the high resolution, including absorption-based micro-CT, or even revealing material properties by small angle X-ray scattering [36, 37]. However, the coherent X-rays in SR can reveal phase contrast depending on the refractive index of different tissues, and diffraction-enhanced imaging is even possible [38]. The easiest phase contrast set-up in a synchrotron is where the sample is in-line with the beamline and detector [34, 35, 39]. As a result of these features, SR-PCI enables high-resolution imaging of soft tissues, such as articular cartilage, potentially providing more accurate information about cartilage degeneration in OA [31, 35].

Here, we focused on two main research objectives. First, can SR-PCI generate sufficient data to quantitate clinically-relevant articular cartilage parameters? Second, how do quantitative image analyses from 3T MRI compare to SR-PCI? Previous proof-of-principle papers using single samples compared SR-PCI to 3T MRI [24, 30, 37, 38]. Here, for the first time, measurements of multiple samples of human articular cartilage from medial tibial condyles of non-OA donors and OA patients permit statistical analyses to compare these imaging modalities.

Materials and methods

Ethics statement and sample collection and preparation

All tissues were obtained according to University of Saskatchewan-approved ethical protocol Bio 13–110. Healthy donor tissues were harvested through the Body Bequeathal Program of the Department of Anatomy, Physiology, and Pharmacology at the University of Saskatchewan. Osteoarthritic tissues were harvested from consenting patients receiving knee replacement surgery by orthopedic surgeons at Saskatoon City Hospital, Canada. All samples were stored in 10% formalin. For imaging protocols, samples were placed in a custom-designed, 3D printed sample holder (Fig 1) and submerged in phosphate-buffered saline (PBS). Imaging was performed on the medial tibial condyle of disarticulated human knee joints from four non-OA and four OA donors (Table 1). To avoid sex-dependent features that might provide unnecessary variance in our statistical analyses, only female tissues were used. Also, as much as possible, cadaveric donor tissues were selected that were age-matched with osteoarthritic tissues in order to control for normal age-related changes. Average age of non-OA samples was 66.0 years, while OA samples were 69.5 years old on average (Table 1). Due to the non-destructive nature of these imaging protocols, the same sample was used for each imaging modality, providing a direct comparison of imaging modalities.

Fig 1. Custom sample holder and SR-PCI field of view.

Fig 1

(A) A custom, non-metal, and waterproof sample holder was 3D-printed with an appropriate size for both samples and imaging machines and with a stable sample position with fine adjustment. (B) Set up for scanning PBS-submerged sample at the CLS beamline BMIT. (C) Top view with blue lines indicating X-ray detector field of view (55mm). (D) Side view with blue lines indicating how multiple X-ray beam heights (2mm) were compiled for each sample (2mm).

Table 1. Tibial plateau sample characteristics.

Group (sample size) Average age (distribution) Sex Clinical designation
Non-OA) n = 4) 66.0 (59, 59, 64, 82) yrs. Female Age-appropriate, mild degeneration
OA (n = 4) 69.5 (59, 71, 72, 76) yrs. Female Severe degeneration requiring knee replacement surgery

Abbreviations: OA = Osteoarthritis; yrs. = years.

3T MR imaging

MRI protocols were carried out on knees scanned in the sagittal plane using an 8-channel knee-coil in the whole-body scanner 3T MRI system (Siemens 3T MRI Scanners, Germany) at the Royal University Hospital Medical Imaging Department, University of Saskatchewan. Based on a pilot study of one sample comparing T1-weighted 3D fast low-angle shot (FLASH) to dual echo steady state (DESS) MRI protocols, FLASH sequences appeared to give more consistent contrast between cartilage and surrounding tissues and so were used for this study (S1 Fig). Specific MRI parameters for FLASH sequences included: Pixel size (312.5×312.5 μm); Field of view (160×160 mm); Slice thickness (1.25 mm); Repetition time (20 msec); Echo time (7.57 msec); Number of averages (1); Echo number (1); Pixel bandwidth (130 Hz); Flip angle (12 degrees).

SR- PCI imaging

In-line SR-PCI imaging was performed at the Biomedical Imaging and Therapy (BMIT) facility 05B1-1 beamline at the Canadian Light Source (CLS), Saskatoon, Canada. The imaging setup consisted of a double crystal bent Lau monochromator tuned to 45 keV imaging energy and a superconducting wiggler X-ray source. Samples were positioned for sagittal imaging in-line with the beam and detector on a rotating scanning stage for CT scanning. Similar to our previous data [35], tomographic data sets were collected at a 5 m sample-to-detector-distance using a beam monitor AA-60 (Hamamatsu) coupled with a Hamamatsu camera C9300-124 with a pixel size of 9x9 μm, binning data 3x3 (so effective pixel size of 27 μm x 27 μm), and an exposure time between 0.03 and 0.06 s, depending on electron ring current. The X-ray detector field of view was 55 mm, and the X-ray beam height was 2 mm (Fig 1C and 1D). Multiple scans were required to image the entire vertical height of each sample, due to the limited beam height, and these scans were stitched together using ImageJ [37].

For each data set, 2500 projections were collected over a 360° rotation (in order to get the entire tibial plateau in the field of view), and a set of 10 flat-field and 10 dark-field images were acquired before and after each scan. Before image reconstruction, projection corrections using flat- and dark-field images were done with an Image J macro plugin. Modified Feld Kamp Algorithm in NRecon V 1.6.10.1 (Bunker, Kontich, Belgium) was used for the non-retrieved image reconstruction to obtain image slices leading to isotropic voxels (i.e., 27 μm slice thickness) based on standard protocol [35, 40]. The two main factors of absorption and refraction contribute to in-line phase-contrast X-ray imaging. The outcomes analyzed were based upon standard reconstruction, where the images were dominated by absorption contrast and the phase contrast contributed to edge enhancement. The images were cropped and exported into FEI Amira 6.0.1 (Oregon) for further analyses.

Image analysis

Articular cartilage was segmented by semi-automated interactive segmentation using the CT Analyzer software package (SkyScan, Kontich, Belgium; see S2 Fig for examples of segmentation). Model-independent 3D cartilage thickness and volume mapping using a Euclidean distance transformation was also done using CT Analyzer, ultimately producing average cartilage thickness and overall cartilage volume measures, as well as a heat map of cartilage thickness. For OA samples, the surface area of the exposed subchondral bone was calculated, and each voxel in this region was assigned an average cartilage thickness value of 0 μm.

Statistical analysis

All statistical analyzes were performed using SPSS software (v20.0. Armonk, NY: IBM Corp.). Since measurements were normally distributed, comparisons between non-OA and OA groups were performed using unpaired, two-tailed t-tests. When comparing MRI and SR-PCI data, Bland-Altman plots were used to evaluate relative differences between the imaging modalities. Ultimately, a one-sample, two-tailed t test was used to see if differences between measures were significantly different from 0, and a regression analysis tested whether the differences in measures scaled with the means. P≤0.05 was considered as statistically significant.

Results

MRI depicted articular cartilage less effectively than SR-PCI

To confirm the status of articular cartilage in the medical school cadaveric (non-OA) and surgical patient (OA) samples of medial tibial condyles, gross anatomical analyses were performed by an orthopaedic surgeon. These analyses revealed that samples of the non-OA group had no obvious cartilage defects, while each sample in the OA group appeared to have severe OA with exposed subchondral bone and often cartilage fibrillation (Fig 2A and 2B; also see Table 1 for sample demographics).

Fig 2. Gross images of representative samples, and virtual slices and segmentations from 3D reconstructions of the same sample from MRI and SR-PCI.

Fig 2

(A, B) Gross images of medial tibial plateaus demonstrate normal articular cartilage appearance of a non-OA sample (A), while cartilage fibrillation and exposed subchondral bone are observed in an OA sample (B). (C, D) Virtual slices of equivalent regions of the same sample, based upon known orientation of the datasets and visual cues from morphology of both the articular cartilage and adjacent subchondral bone, from 3D reconstructed MRI (C) and SR-PCI (D) datasets suggest that SR-PCI has higher resolution than MRI. (E, F) Cartilage and bone segmentations on the same virtual slices as in panels C and D from 3D reconstructed MRI (E) and SR-PCI (F) datasets. Scale bars: A,B = 1cm; C-F = 0.5cm.

To evaluate any differences in resolution and contrast between the two imaging modalities, each sample was imaged by 3T MRI and SR-PCI, and virtual sections from the 3D reconstructed datasets were generated. Equivalent virtual sections from the same sample were estimated based upon known orientation of the datasets and visual cues from morphology of both the articular cartilage and adjacent subchondral bone (Fig 2C and 2D). Qualitatively, both MRI and SR-PCI could distinguish articular cartilage, subchondral bone, and surrounding fluid (i.e., PBS, which simulated synovial fluid). However, as expected from the equipment and imaging parameters used (see Methods), SR-PCI provided much higher resolution images than MRI, despite the fact that the MRI virtual section was orthogonal to the large anisotropic dimension of the MRI voxels (i.e., 1.25 mm slice thickness; Fig 2C and 2D). Also, the virtual sections from MRI showed poorer contrast at the tissue interfaces between articular cartilage and subchondral bone and between articular cartilage and surrounding fluid, compared to virtual sections from SR-PCI. Trabecular features in subchondral bone, another diagnostic of OA [30], were clearly detailed in SR-PCI, but not MRI (Fig 2C and 2D).

Segmentation of articular cartilage from the 3D image datasets allowed relative levels of cartilage thickness to be indicated with color heat maps, showing clear differences between experimental groups and also between imaging modalities. For example, OA samples had multiple areas of severe articular cartilage thinning (red) or absence, particularly where the medial tibial condyle articulated with the medial femoral condyle, compared to non-OA samples (Fig 3). Also, compared to MRI, SR-PCI color maps of articular cartilage thickness were much less pixelated with gradual, as opposed to abrupt, changes in coloration, again consistent with the much higher resolution of SR-PCI (27 μm x 27 μm x 27 μm), compared with MRI (312 μm x 312 μm x 1250 μm (see Methods); Fig 3). In these surface views, the anisotropic dimension of the MRI voxel was evident. In total, these results led to the conclusion that SR-PCI generated more effective depictions of articular cartilage than clinical MRI.

Fig 3. Representative heat-mapped images showing cartilage thickness.

Fig 3

(A-D) After image segmentation of articular cartilage from medial tibial condyles, regional cartilage thickness distribution (blue = thickest, red = thinnest) in representative non-OA samples suggested that MRI estimated higher values, compared to PCI. (E-H) A similar trend was observed in representative OA samples, which also contained large areas without any detectable cartilage. Scale bars: A-H = 1cm.

Both MRI and SR-PCI revealed significant decreases in articular cartilage parameters of OA samples, compared to non-OA samples

For quantitative comparisons, average cartilage thickness and overall cartilage volume were calculated from segmented regions of the 3D datasets from both 3T MRI and SR-PCI. Histological Safranin O staining of one sample confirmed the identity of cartilage in the segmented region and also provided validation of the thickness measures (S2 Fig; Table 2). Both imaging modalities revealed that the average articular cartilage thickness was significantly decreased in the OA group, compared to the non-OA group (Fig 4A and 4B). For MRI data, the non-OA average thickness was 2280 ±157 μm, while the OA average thickness was 1831 ±179 μm (p = 0.009; Table 2). For SR-PCI data, the non-OA average cartilage thickness was 2078 ±210 μm, whereas the OA measured 1648 ±243 μm (p = 0.037). Accordingly, average cartilage thickness decreased in OA samples by 19.7% for MRI data and 20.7% for SR-PCI data.

Table 2. Sample measurements.

Group Samples MRI: Average cartilage thickness* (μm) SR-PCI: Average cartilage thickness* (μm) MRI: Overall cartilage volume (ml) SR-PCI: Overall cartilage volume (ml)
Non-OA 1 2290 1879 2.476 2.139
2 2054 1931 2.674 2.758
3 2389 2173 2.200 1.963
4 2386 2328 2.432 1.643
Non-OA average (± SD) 2280 (±157) 2078 (±210) 2.446 (±0.195) 2.126 (±0.469)
OA 1 1646 1454 1.785 1.027
2 1725 1588 1.792 1.578
3 1915 1546 1.728 1.563
4 2039 2002 1.488 1.498
OA average (± SD) 1831 (±179) 1648 (±243) 1.698 (±0.143) 1.417 (±0.262)

*includes 0 values for voxels over the exposed subchondral bone surface area in OA samples

Fig 4. Both MRI and SR-PCI demonstrated significant decreases in clinically-relevant articular cartilage parameters.

Fig 4

(A, B) Quantitative analyses of average cartilage thickness (μm) showed that OA samples were significantly thinner than non-OA samples from both MRI (A, **p = 0.009) and SR-PCI data (B, *p = 0.037). (C, D) Quantitative analyses of overall cartilage volume (ml) showed that OA samples had significantly less cartilage than non-OA samples from both MRI (C, ***p = 0.001) and SR-PCI data (D, *p = 0.039).

Similarly, both imaging modalities demonstrated significantly reduced overall articular cartilage volume in the OA group, compared to the non-OA group (Fig 4C and 4D). For MRI data, the non-OA cartilage volume was 2.446 ±0.195 ml, compared to 1.698 ±0.143 ml for the OA group (p = 0.001; Table 2). For SR-PCI data, the non-OA cartilage volume was 2.126 ±0.469 ml, while the OA group measured 1.417 ±0.262 ml (p = 0.039). The decrease in overall cartilage volume of OA samples was 30.6% for MRI data and 33.4% for SR-PCI data. In summary, analyses of articular cartilage from MRI and SR-PCI data indicated that both imaging methods revealed significantly reduced average cartilage thickness and overall cartilage volume in the OA group, compared to the non-OA group.

MRI over-estimated articular cartilage parameters, compared to SR-PCI

While both MRI and SR-PCI were able to detect significant differences in articular cartilage parameters between severe OA and non-OA, they did not show equivalent measures for each parameter in each group. Compared to SR-PCI, average cartilage thickness and overall cartilage volume trended higher in MRI, although the differences were not statistically significant when considering each group separately (Fig 5). Measurements from MRI data produced an average thickness of articular cartilage in non-OA samples that trended 9.7% higher (p = 0.078) than those from SR-PCI data (2280 ±157 μm and 2078 ±210 μm, respectively; Table 2). For OA samples, measurements from MRI data produced an overall cartilage volume that trended 11.1% higher (p = 0.078) than those from SR-PCI data (1831 ±179 μm and 1648 ±243 μm, respectively; Table 2). Regarding overall cartilage volume in non-OA samples, measurements from MRI data trended 15.1% higher (p = 0.174) than those from SR-PCI data (2.446 ±0.195 ml and 2.126 ±0.469 ml, respectively; Table 2). For OA samples, measurements from MRI data trended 19.8% higher (p = 0.188) than those from SR-PCI data (1.698 ±0.143 ml and 1.417 ±0.262 ml, respectively; Table 2).

Fig 5. Comparisons of imaging modalities with only one experimental group were inconclusive.

Fig 5

(A, B) Quantitative analyses of average cartilage thickness (A) and overall cartilage volume (B) of the non-OA samples trended towards an increased measure in MRI, compared to SR-PCI, but the results were not statistically significant. (C, D) Quantitative analyses of average cartilage thickness (C) and overall cartilage volume (D) of the OA samples trended towards an increased measure in MRI, compared to SR-PCI, but the results were not statistically significant.

Bland-Altman analyses across both non-OA and OA groups were used to compare dissimilarities between MRI and SR-PCI in obtaining two clinically-relevant measurements of articular cartilage. Simply combining non-OA and OA sample data did not find significant differences between MRI and SR-PCI measurements, likely because of the wide variation in measurements between non-OA and OA samples within each imaging modality. Bland-Altman plots reflected that MRI datasets calculated larger values for both average cartilage thickness and overall cartilage volume than SR-PCI datasets (Fig 6A and 6C). Indeed, the differences in MRI and SR-PCI measurements of each sample’s average cartilage thickness (p = 0.005) and overall cartilage volume (p = 0.033) were statistically greater than zero. MRI data for average cartilage thickness was 11.0% (±8.2%) higher than SR-PCI data, while overall cartilage volume was 21.2% (±26.3%) higher for MRI data than SR-PCI data. Finally, regression analyses confirmed that the difference between measures of cartilage thickness (p = 0.646; R^2 = 0.038) or cartilage volume (p = 0.489; R^2 = 0.083) was not significantly related to the scale of the measures (Fig 6B and 6D). In total, these data clearly demonstrated that, compared to SR-PCI, MRI over-estimates clinically-relevant parameters of articular cartilage health when imaging samples ex vivo.

Fig 6. MRI significantly over-estimated clinically-relevant articular cartilage parameters, compared to SR-PCI.

Fig 6

(A) Bland-Altman analyses of average cartilage thickness suggested that MRI over-estimated measurements, compared to SR-PCI; this finding was verified as significant by a one-sample t-test of differences compared to 0 (p = 0.005). (B) Regression analysis confirmed that the difference between the measures from MRI and SR-PCI was independent of the scale of the measurement (p = 0.646; R^2 = 0.038). (C) Bland-Altman analyses of overall cartilage volume suggested that MRI over-estimated measurements, compared to SR-PCI; this finding was verified as significant by a one-sample t-test of differences compared to 0 (p = 0.033). (D) Regression analysis confirmed that the difference between the measures from MRI and SR-PCI was independent of the scale of the measurement (p = 0.489; R^2 = 0.083). For Bland-Altman plots (A,C), the x-axis is labelled at difference = 0, dotted black line represents the mean difference among samples, and dotted blue lines represent 95% confidence intervals from the mean difference.

Discussion

Because insufficient biomarkers exist for the early diagnosis of OA, new imaging approaches to improve the diagnosis of OA are needed. Such improvements also will improve the ability to assess progression of this complex disease, predict final joint damage, and monitor the effectiveness of experimental therapies [1, 7].

Clinical MRI has been adapted for quantitative morphological assessment of articular cartilage, notably to reveal average cartilage thickness and overall cartilage volume. However, the resolution of clinical MRI might not offer the capability to delineate details of articular cartilage, meaning that early cases of OA might go undiagnosed [28, 29, 41]. Recent imaging innovations, such as grating-based X-ray PCI-CT (not in-line) and SR-PCI, have been highlighted in proof-of-principle studies for high-resolution evaluation of clinically-relevant articular cartilage parameters [24, 30, 42, 43].

Here, we provided for the first time a direct comparison of MRI and SR-PCI techniques on multiple non-OA and OA human articular cartilage samples, using image segmentation to quantitate average cartilage thickness and overall cartilage volume. By assessing morphological features of cartilage that may be related to function, these imaging techniques make it possible to distinguish between healthy and OA cartilage. While 3D-DESS MRI protocols are often a sequence of choice for quantitative measurements of articular cartilage (e.g., [44]), our pilot imaging suggested more consistent contrast between cartilage and surrounding tissues using the FLASH protocol (i.e., cartilage had lighter pixels than both the fluid and bone). A future study using DESS images would address this potentially influential decision. Both MRI and SR-PCI revealed that the OA group had significantly lower average cartilage thickness and overall cartilage volume, compared to the non-OA group. The OA samples in this study were very severe cases, since they were recovered from knees of patients undergoing total knee replacement surgeries. In fact, articular cartilage in all OA samples had been depleted so much as to expose large areas of subchondral bone. Perhaps if the OA samples had less severe loss of articular cartilage, then both imaging modalities might not have revealed significant decreases. Future studies with less severe cases of OA will better discriminate whether 3T MRI or SR-PCI can diagnose early OA more accurately.

Qualitative evaluations of articular cartilage images demonstrated an increased ability of SR-PCI to distinguish tissue boundaries, compared to MRI. Virtual sections from the 3D image reconstructions illustrated that SR-PCI defined better the boundaries between bone and articular cartilage or between articular cartilage and surrounding fluid. Such enhanced edge contrast is a characteristic feature of PCI, since the image reconstructions incorporate phase diffraction shifts from one medium to another [38]. Additionally, edge contrast in MRI images could suffer from a chemical-shifts artifact, due to different water and fat compositions of various joint tissues [41]. In MRI, gradient imaging and fat suppression algorithms can be used to saturate the excitation of fat protons, which may improve contrast resolution between cartilage and free fluid structures, such as synovial fluid, or even help identify subchondral bone cysts [41]. Changes to subchondral bone are also characteristic of OA [1, 2], so the ability of SR-PCI to provide fine detail of subchondral bone might also be advantageous for the early diagnosis of OA.

Quantitative evaluations of articular cartilage images in the study groups showed a significantly higher average thickness and overall volume from MRI data, compared to SR-PCI data, which is likely due to the difference in imaging resolution strengths of the two modalities. Color map visualization of cartilage thickness suggested that SR-PCI could provide a better description of morphological features, including cartilage erosion, than clinical MRI. Individual articular cartilage parameters also trended higher for each experimental group in measurements from MRI data, compared to those from SR-PCI. Bland-Altman analyses confirmed a significant increase in both average cartilage thickness and cartilage volume in measurements from MRI data compared with SR-PCI. Overestimation of cartilage thickness and volume are probably related to reduced imaging spatial resolution in MRI, compared to SR-PCI, which then could cause errors in subsequent measurements. Unexpectedly, despite decreased resolution of MRI, the standard deviations of MRI measures were lower. For example, standard deviation was 10% of the average cartilage thickness for MRI images of OA samples, while it was 15% for SR-PCI images. Given that MRI overestimated measures, compared to SR-PCI, we speculate that partial volume effects contributed to the decreased standard deviation of MRI, especially in thinner regions of articular cartilage.

Surface views of the cartilage showed the anisotropic and relatively large (1.25 mm) slice thickness component of the MRI voxel (running top-to-bottom in Fig 3 images), which was a major factor in the dramatically decreased resolution of MRI. However, since this dimension was orthogonal to the cross-section views (see square pixels in Fig 2C), it likely affected measures of overall cartilage volume much more than average cartilage thickness measures. Overall, the nominal resolution of these 3T MR images would be 312.5 μm x 312.5 μm x 1250 μm voxel, while the nominal resolution of SR-PCI would be 27 μm x 27 μm x 27 μm voxel (see Methods). Therefore, compared to MRI, SR-PCI had several orders of magnitude better resolution (20 x 103 μm3 vs. MRI’s 12.2 x 107 μm3), even that being limited in principle by the detector resolution and settings employed. As the superficial layer of articular cartilage is approximately 300 μm thick, loss of this layer and the beginnings of OA could be present, but not detectable with MRI [28, 4547].

So, was 3T MRI or SR-PCI more accurate in revealing clinically-relevant articular cartilage parameters? Unfortunately, no gold standard exists for answering this question with these samples, so direct comparison between the actual measurements and those from MRI or SR-PCI is not easy. The articular cartilage measurements reported here for both imaging modalities, such as average cartilage thickness of 2280 μm (from MRI) or 2078 μm (from SR-PCI), in the medial tibial condyle of non-OA specimens were comparable to previous studies [7, 19, 24, 30, 39]. Histological preparations might be a good gold standard, but they also have a measurement error due to processing, which may cause shrinkage due to specimen dehydration or other structural changes that occur during embedding, sectioning, and staining of the tissues. While imperfect as a gold standard, our histological sections provided further support for the articular cartilage measures reported here for these imaging modalities. Future test-retest scans and evaluating inter-reader variability for the semi-automated segmentation would increase evaluation of accuracies of MRI and SR-PCI in depicting articular cartilage. The potential question of which modality is preferred, however, must be based on the clinical indication and question. MRI is good at evaluating the gross morphology and structure of the cartilage. SR-PCI could be better at visualization of not only the interface between cartilage and bone, but also fine cartilage details, such as surface morphology and minor defects that could lead to disease progression.

At least for the severe cases of OA examined here, these data suggest that overall cartilage volume might be a better diagnostic of articular cartilage health than average cartilage thickness. Regardless of the imaging modality employed, OA measures for average cartilage thickness were 20% lower than non-OA measures. Greater decreases in overall cartilage volume were measured by both imaging modalities, with OA measures over 30% lower than non-OA measures. A future study would be useful evaluating the influence of different available cartilage thickness measurement algorithms on similar analyses as performed here.

SR-PCI might provide dramatically improved cartilage imaging, compared to 3T MRI, but unfortunately, implementing any synchrotron-based imaging for clinical applications is currently impractical. Synchrotrons are not commonly available, and they are extremely complicated and expensive to establish, requiring expertise across science and engineering disciplines and massive budgets. In addition, protocols would need to be developed to address safety concerns about radiation dose to patients and potential movement of patients during scanning. Therefore, SR-PCI still has limited clinical applications currently, but preclinical animal studies are prime targets for synchrotron-based imaging. Large animal studies, such as pig, can replicate gross features of human articular cartilage disease progression and are useful in evaluating preclinical therapeutic strategies [48]. Also, a recent development in the field is to image living animals using synchrotron-based techniques, even imaging the same animal multiple times, potentiating longitudinal studies of OA progression from early stages [37, 4953].

Conclusion

Taken together, these findings clearly demonstrated that SR-PCI provided high-resolution images that may improve assessment of clinically relevant articular cartilage parameters, such as cartilage thickness and overall volume. In addition, SR-PCI can highlight fine details of the cartilage surface, interfaces between cartilage and bone, and even fine details of the subchondral bone structure. Comparing 3T MRI to SR-PCI, both MRI and SR-PCI revealed that the OA group had significantly lower average cartilage thickness and overall cartilage volume, compared to the non-OA group. However, MRI data showed a significantly higher average thickness and overall volume, compared to SR-PCI data, which is likely due to the difference in imaging resolution strengths of the two modalities. As such, with further development, SR-PCI might increase accurate evaluation of morphological changes in articular cartilage not only for early diagnosis of OA disease, but also for monitoring disease progression and response to treatment.

Supporting information

S1 Fig. Pilot comparison of MRI sequences suggested that FLASH gave more consistent contrast at cartilage boundaries than DESS.

(A, B) Virtual slices of similar regions of the same sample from 3D reconstructed MRI datasets using either FLASH (A) or DESS (B) imaging sequences suggested that contrast between the cartilage and overlying fluid and subchondral bone was more consistent with FLASH. Scale bars: A,B = 0.5cm.

(EPS)

S2 Fig. A histological stain of a sectioned sample shows a similar cartilage thickness as calculated from 3D reconstructed image analyses.

A tissue section of a non-OA sample was stained with Safranin O, independently confirming the presence of cartilage, meanwhile providing independent support for the measures of cartilage thickness obtained from the segmented cartilage on virtual slices. Scale bar = 0.4cm.

(EPS)

Acknowledgments

We thank the selfless donors of cadavers to the Body Bequeathal Program in the Department of Anatomy, Physiology, and Pharmacology, and also appreciate the donors of surgically removed OA tissues during total knee arthroplasty at City Hospital of Saskatoon. Thanks to Bianca Sarkis for helping prepare samples for histology and to Shreyas Jois, Aditya Manek, and the University of Saskatchewan College of Medicine Histology Core Facility.

Data Availability

In order that others may replicate or extend our study findings, raw image files from all samples can be found at https://globus.usask.ca/file-manager?origin_id=ef36db6f-8e10-4b8b-93b5-ec8e895a7511&origin_path=%2F.

Funding Statement

This study was supported by grants to BFE: Royal University Hospital (RUH) Foundation, the Saskatchewan Health Research Foundation (SHRF) Establishment Grant, and the Canadian Institutes of Health Research (CIHR) project grant 148683. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Part of the research described in this paper was performed at the Canadian Light Source, a national research facility of the University of Saskatchewan, which is supported by the Canada Foundation for Innovation (CFI), the Natural Sciences and Engineering Research Council (NSERC), the National Research Council (NRC), CIHR, the Government of Saskatchewan, and the University of Saskatchewan.

References

  • 1.Martel-Pelletier J, Barr A, Cicuttini F. Osteoarthritis//Nat Rev Dis Primers. 2016; 2: 16072. [DOI] [PubMed] [Google Scholar]
  • 2.Peat G, Croft P, Hay E. Clinical assessment of the osteoarthritis patient. Best Practice & Research Clinical Rheumatology. 2001;15(4):527–44. doi: 10.1053/berh.2001.0171 [DOI] [PubMed] [Google Scholar]
  • 3.Madry H, Kon E, Condello V, Peretti GM, Steinwachs M, Seil R, et al. Early osteoarthritis of the knee. Knee Surgery, Sports Traumatology, Arthroscopy. 2016;24(6):1753–62. doi: 10.1007/s00167-016-4068-3 [DOI] [PubMed] [Google Scholar]
  • 4.Teoh YX, Lai KW, Usman J, Goh SL, Mohafez H, Hasikin K, et al. Discovering Knee Osteoarthritis Imaging Features for Diagnosis and Prognosis: Review of Manual Imaging Grading and Machine Learning Approaches. Journal of Healthcare Engineering. 2022;2022. doi: 10.1155/2022/4138666 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 5.Mobasheri A, Kapoor M, Ali SA, Lang A, Madry H. The future of deep phenotyping in osteoarthritis: How can high throughput omics technologies advance our understanding of the cellular and molecular taxonomy of the disease? Osteoarthritis and Cartilage Open. 2021;3(4):100144. doi: 10.1016/j.ocarto.2021.100144 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Coan P, Mollenhauer J, Wagner A, Muehleman C, Bravin A. Analyzer-based imaging technique in tomography of cartilage and metal implants: a study at the ESRF. European journal of radiology. 2008;68(3):S41–S8. doi: 10.1016/j.ejrad.2008.04.036 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Coan P, Bamberg F, Diemoz PC, Bravin A, Timpert K, Mützel E, et al. Characterization of osteoarthritic and normal human patella cartilage by computed tomography X-ray phase-contrast imaging: a feasibility study. Investigative radiology. 2010;45(7):437–44. doi: 10.1097/RLI.0b013e3181e193bd [DOI] [PubMed] [Google Scholar]
  • 8.Lee YS, Heo E-A, Jun HY, Kang SH, Kim HS, Lee MS, et al. Articular cartilage imaging by the use of phase-contrast tomography in a collagen-induced arthritis mouse model. Academic radiology. 2010;17(2):244–50. doi: 10.1016/j.acra.2009.09.015 [DOI] [PubMed] [Google Scholar]
  • 9.Guermazi A, Hayashi D, Roemer FW, Felson DT. Osteoarthritis: a review of strengths and weaknesses of different imaging options. Rheumatic Disease Clinics. 2013;39(3):567–91. doi: 10.1016/j.rdc.2013.02.001 [DOI] [PubMed] [Google Scholar]
  • 10.Braun HJ, Gold GE. Diagnosis of osteoarthritis: imaging. Bone. 2012;51(2):278–88. doi: 10.1016/j.bone.2011.11.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Li J, Zhong Z, Connor D, Mollenhauer J, Muehleman C. Phase-sensitive X-ray imaging of synovial joints. Osteoarthritis and cartilage. 2009;17(9):1193–6. doi: 10.1016/j.joca.2009.03.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Nagarajan MB, Coan P, Huber MB, Diemoz PC, Glaser C, Wismüller A. Computer-aided diagnosis in phase contrast imaging X-ray computed tomography for quantitative characterization of ex vivo human patellar cartilage. IEEE Transactions on Biomedical Engineering. 2013;60(10):2896–903. doi: 10.1109/TBME.2013.2266325 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Burstein D, Gray M, Mosher T, Dardzinski B. Measures of molecular composition and structure in osteoarthritis. Radiologic Clinics. 2009;47(4):675–86. doi: 10.1016/j.rcl.2009.04.003 [DOI] [PubMed] [Google Scholar]
  • 14.Bolbos R, Benoit‐Cattin H, Langlois JB, Chomel A, Chereul E, Odet C, et al. Measurement of knee cartilage thickness using MRI: a reproducibility study in a meniscectomized guinea pig model of osteoarthritis. NMR in Biomedicine: An International Journal Devoted to the Development and Application of Magnetic Resonance In vivo. 2008;21(4):366–75. [DOI] [PubMed] [Google Scholar]
  • 15.Gold GE, Chen CA, Koo S, Hargreaves BA, Bangerter NK. Recent advances in MRI of articular cartilage. AJR American journal of roentgenology. 2009;193(3):628. doi: 10.2214/AJR.09.3042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Buck RJ, Wyman BT, Le Graverand MPH, Wirth W, Eckstein F, Investigators A. An efficient subset of morphological measures for articular cartilage in the healthy and diseased human knee. Magnetic resonance in medicine. 2010;63(3):680–90. doi: 10.1002/mrm.22207 [DOI] [PubMed] [Google Scholar]
  • 17.Julkunen P, Korhonen R, Nissi M, Jurvelin J. Mechanical characterization of articular cartilage by combining magnetic resonance imaging and finite-element analysis—a potential functional imaging technique. Physics in Medicine & Biology. 2008;53(9):2425. doi: 10.1088/0031-9155/53/9/014 [DOI] [PubMed] [Google Scholar]
  • 18.Trattnig S, Domayer S, Welsch G, Mosher T, Eckstein F. MR imaging of cartilage and its repair in the knee-a review. European radiology. 2009;19(7):1582–94. doi: 10.1007/s00330-009-1352-3 [DOI] [PubMed] [Google Scholar]
  • 19.Horng A, Brun E, Mittone A, Gasilov S, Weber L, Geith T, et al. Cartilage and soft tissue imaging using X-rays: propagation-based phase-contrast computed tomography of the human knee in comparison with clinical imaging techniques and histology. Investigative radiology. 2014;49(9):627–34. doi: 10.1097/RLI.0000000000000063 [DOI] [PubMed] [Google Scholar]
  • 20.Schneider E, Nevitt M, McCulloch C, Cicuttini FM, Duryea J, Eckstein F, et al. Equivalence and precision of knee cartilage morphometry between different segmentation teams, cartilage regions, and MR acquisitions. Osteoarthritis and cartilage. 2012;20(8):869–79. doi: 10.1016/j.joca.2012.04.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Panfilov E, Tiulpin A, Nieminen MT, Saarakkala S, Casula V. Deep learning‐based segmentation of knee MRI for fully automatic subregional morphological assessment of cartilage tissues: Data from the Osteoarthritis Initiative. Journal of Orthopaedic Research®. 2021. doi: 10.1002/jor.25150 [DOI] [PubMed] [Google Scholar]
  • 22.Crema MD, Roemer FW, Marra MD, Burstein D, Gold GE, Eckstein F, et al. Articular cartilage in the knee: current MR imaging techniques and applications in clinical practice and research. Radiographics. 2011;31(1):37. doi: 10.1148/rg.311105084 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Maly MR, Acker SM, Totterman S, Tamez-Peña J, Stratford PW, Callaghan JP, et al. Knee adduction moment relates to medial femoral and tibial cartilage morphology in clinical knee osteoarthritis. Journal of biomechanics. 2015;48(12):3495–501. doi: 10.1016/j.jbiomech.2015.04.039 [DOI] [PubMed] [Google Scholar]
  • 24.Herzen J, Karampinos DC, Foehr P, Birnbacher L, Viermetz M, Burgkart R, et al. 3D grating-based X-ray phase-contrast computed tomography for high-resolution quantitative assessment of cartilage: An experimental feasibility study with 3T MRI, 7T MRI and biomechanical correlation. Plos one. 2019;14(2):e0212106. doi: 10.1371/journal.pone.0212106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lammentausta E, Kiviranta P, Nissi M, Laasanen M, Kiviranta I, Nieminen M, et al. T2 relaxation time and delayed gadolinium‐enhanced MRI of cartilage (dGEMRIC) of human patellar cartilage at 1.5 T and 9.4 T: Relationships with tissue mechanical properties. Journal of orthopaedic research. 2006;24(3):366–74. doi: 10.1002/jor.20041 [DOI] [PubMed] [Google Scholar]
  • 26.Link TM, Stahl R, Woertler K. Cartilage imaging: motivation, techniques, current and future significance. European radiology. 2007;17(5):1135–46. doi: 10.1007/s00330-006-0453-5 [DOI] [PubMed] [Google Scholar]
  • 27.Liebl H, Joseph G, Nevitt MC, Singh N, Heilmeier U, Subburaj K, et al. Early T2 changes predict onset of radiographic knee osteoarthritis: data from the osteoarthritis initiative. Annals of the rheumatic diseases. 2015;74(7):1353–9. doi: 10.1136/annrheumdis-2013-204157 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Cohen ZA, Mccarthy DM, Kwak SD, Legrand P, Fogarasi F, Ciaccio EJ, et al. Knee cartilage topography, thickness, and contact areas from MRI: in-vitro calibration and in-vivo measurements. Osteoarthritis and cartilage. 1999;7(1):95–109. doi: 10.1053/joca.1998.0165 [DOI] [PubMed] [Google Scholar]
  • 29.Rousseau J-C, Delmas PD. Biological markers in osteoarthritis. Nature Clinical Practice Rheumatology. 2007;3(6):346–56. doi: 10.1038/ncprheum0508 [DOI] [PubMed] [Google Scholar]
  • 30.Horng A, Stroebel J, Geith T, Milz S, Pacureanu A, Yang Y, et al. Multiscale X-ray phase contrast imaging of human cartilage for investigating osteoarthritis formation. Journal of Biomedical Science. 2021;28(1):1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Jungmann PM, Kraus MS, Nardo L, Liebl H, Alizai H, Joseph GB, et al. T2 relaxation time measurements are limited in monitoring progression, once advanced cartilage defects at the knee occur: Longitudinal data from the osteoarthritis initiative. Journal of Magnetic Resonance Imaging. 2013;38(6):1415–24. doi: 10.1002/jmri.24137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Matsumoto T, Shimizu R, Uesugi K. In vivo monitoring of bone microstructure by propagation-based phase-contrast computed tomography using monochromatic synchrotron light. Laboratory Investigation. 2020;100(1):72–83. doi: 10.1038/s41374-019-0337-3 [DOI] [PubMed] [Google Scholar]
  • 33.Duan X, Li N, Chen X, Zhu N. Characterization of Tissue Scaffolds Using Synchrotron Radiation Microcomputed Tomography Imaging. Tissue Engineering Part C: Methods. 2021;27(11):573–88. doi: 10.1089/ten.TEC.2021.0155 [DOI] [PubMed] [Google Scholar]
  • 34.Bartels M, Hernandez VH, Krenkel M, Moser T, Salditt T. Phase contrast tomography of the mouse cochlea at microfocus x-ray sources. Applied Physics Letters. 2013;103(8):083703. [Google Scholar]
  • 35.Olubamiji AD, Izadifar Z, Zhu N, Chang T, Chen X, Eames BF. Using synchrotron radiation inline phase-contrast imaging computed tomography to visualize three-dimensional printed hybrid constructs for cartilage tissue engineering. Journal of synchrotron radiation. 2016;23(3):802–12. doi: 10.1107/S1600577516002344 [DOI] [PubMed] [Google Scholar]
  • 36.Carter Y, Thomas CDL, Clement JG, Peele AG, Hannah K, Cooper DM. Variation in osteocyte lacunar morphology and density in the human femur—a synchrotron radiation micro-CT study. Bone. 2013;52(1):126–32. doi: 10.1016/j.bone.2012.09.010 [DOI] [PubMed] [Google Scholar]
  • 37.Waddingham MT, Tsuchimochi H, Sonobe T, Asano R, Jin H, Ow CP, et al. Using Synchrotron Radiation Imaging Techniques to Elucidate the Actions of Hexarelin in the Heart of Small Animal Models. Frontiers in Physiology. 2022:2295. doi: 10.3389/fphys.2021.766818 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Izadifar Z, Chapman LD, Chen X. Computed tomography diffraction-enhanced imaging for in situ visualization of tissue scaffolds implanted in cartilage. Tissue Engineering Part C: Methods. 2014;20(2):140–8. doi: 10.1089/ten.TEC.2013.0138 [DOI] [PubMed] [Google Scholar]
  • 39.Tang M, Zhi R, Sun C, Wang X, Liu C, editors. Evaluating the value of synchrotron radiation phase-contrast CT imaging in the study of knee joint microstructure. E3S Web of Conferences; 2021: EDP Sciences. [Google Scholar]
  • 40.Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nature methods. 2012;9(7):671–5. doi: 10.1038/nmeth.2089 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.McGibbon CA, Bencardino J, Palmer WE. Subchondral bone and cartilage thickness from MRI: effects of chemical-shift artifact. Magnetic Resonance Materials in Physics, Biology and Medicine. 2003;16(1):1–9. doi: 10.1007/s10334-003-0001-0 [DOI] [PubMed] [Google Scholar]
  • 42.Koo S, Gold G, Andriacchi T. Considerations in measuring cartilage thickness using MRI: factors influencing reproducibility and accuracy. Osteoarthritis and cartilage. 2005;13(9):782–9. doi: 10.1016/j.joca.2005.04.013 [DOI] [PubMed] [Google Scholar]
  • 43.Olubamiji AD, Zhu N, Chang T, Nwankwo CK, Izadifar Z, Honaramooz A, et al. Traditional invasive and synchrotron-based noninvasive assessments of three-dimensional-printed hybrid cartilage constructs in situ. Tissue Engineering Part C: Methods. 2017;23(3):156–68. doi: 10.1089/ten.TEC.2016.0368 [DOI] [PubMed] [Google Scholar]
  • 44.Eckstein F, Collins J, Nevitt M, Lynch J, Kraus V, Katz J, et al. Brief report: cartilage thickness change as an imaging biomarker of knee osteoarthritis progression: data from the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium. Arthritis & rheumatology. 2015;67(12):3184–9. doi: 10.1002/art.39324 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Recht MP, Piraino DW, Paletta GA, Schils JP, Belhobek GH. Accuracy of fat-suppressed three-dimensional spoiled gradient-echo FLASH MR imaging in the detection of patellofemoral articular cartilage abnormalities. Radiology. 1996;198(1):209–12. doi: 10.1148/radiology.198.1.8539380 [DOI] [PubMed] [Google Scholar]
  • 46.Fox AS, Bedi A. ja SA Rodeo. The basic science of articular cartilage: Structure, composition, and function Sports Health. 2009;1:461–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Griebel AJ, Trippel SB, Emery NC, Neu CP. Noninvasive assessment of osteoarthritis severity in human explants by multicontrast MRI. Magnetic Resonance in Medicine. 2014;71(2):807–14. doi: 10.1002/mrm.24725 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Sardroud HA, Wanlin T, Chen X, Eames BF. Cartilage tissue engineering approaches need to assess fibrocartilage when hydrogel constructs are mechanically loaded. Frontiers in Bioengineering and Biotechnology. 2021;9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Inocencio IM, Tran NT, Nakamura S, Khor SJ, Wiersma M, Stoecker K, et al. Increased peak end-expiratory pressure in ventilated preterm lambs changes cerebral microvascular perfusion: direct synchrotron microangiography assessment. Journal of Applied Physiology. 2020;129(5):1075–84. doi: 10.1152/japplphysiol.00652.2020 [DOI] [PubMed] [Google Scholar]
  • 50.Luan X, Belev G, Tam JS, Jagadeeshan S, Hassan N, Gioino P, et al. Cystic fibrosis swine fail to secrete airway surface liquid in response to inhalation of pathogens. Nature communications. 2017;8(1):1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Morgan KS, Parsons D, Cmielewski P, McCarron A, Gradl R, Farrow N, et al. Methods for dynamic synchrotron X-ray respiratory imaging in live animals. Journal of Synchrotron Radiation. 2020;27(1):164–75. doi: 10.1107/S1600577519014863 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Novakofski KD, Pownder SL, Koff MF, Williams RM, Potter HG, Fortier LA. High-resolution methods for diagnosing cartilage damage in vivo. Cartilage. 2016;7(1):39–51. doi: 10.1177/1947603515602307 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Harrison KD, Sales E, Hiebert BD, Panahifar A, Zhu N, Arnason T, et al. Direct Assessment of Rabbit Cortical Bone Basic Multicellular Unit Longitudinal Erosion Rate: A 4D Synchrotron‐Based Approach. Journal of Bone and Mineral Research. 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Zhentian Wang

13 Feb 2023

PONE-D-22-34378Clinical MRI overestimates articular cartilage thickness and volume compared to synchrotron radiation phase-contrast imagingPLOS ONE

Dear Dr. Eames,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

 Reviewer #2 has raised important concerns about the study design and the MRI protocol used in this study. Please address these comments with special cares. 

Please submit your revised manuscript by Mar 30 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Zhentian Wang, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following in the Acknowledgments Section of your manuscript:

"This study was supported by grants to BFE: Royal University Hospital (RUH) Foundation, the Saskatchewan Health Research Foundation (SHRF) Establishment Grant, and the Canadian Institutes of Health Research (CIHR) project grant 148683.  We thank the selfless donors of cadavers to the Body Bequeathal Program in the Department of Anatomy, Physiology, and Pharmacology, and also appreciate the donors of surgically removed OA tissues during total knee arthroplasty at City Hospital of Saskatoon.  Part of the research described in this paper was performed at the Canadian Light Source, a national research facility of the University of Saskatchewan, which is supported by the Canada Foundation for Innovation (CFI), the Natural Sciences and Engineering Research Council (NSERC), the National Research Council (NRC), CIHR, the Government of Saskatchewan, and the University of Saskatchewan."

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The author(s) received no specific funding for this work."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

5. Thank you for stating the following financial disclosure:

"The author(s) received no specific funding for this work."

At this time, please address the following queries:

a)        Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b)        State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c)        If any authors received a salary from any of your funders, please state which authors and which funders.

d)        If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

6. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.

7. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Accurate evaluation of the morphological characteristics of articular cartilage is essential for the early detection and diagnosis of osteoarthritis (OA). Currently, 3T magnetic resonance imaging (MRI) is widely used to detect OA in clinic. Meanwhile, synchrotron radiation phase-contrast imaging computed tomography (SR-PCI), as a unique imaging technique, is capable of high-resolution imaging of biological soft tissues, including articular cartilage. In this study, the authors evaluated human articular cartilage quantitatively based on MRI and SR-PCI simultaneously. Compared with the non-OA group, the average cartilage thickness and cartilage volume in the OA group were significantly reduced by both imaging methods. In addition, the high resolution SR-PCI is able to map the cartilage surface more accurately than MRI, thus providing more accurate information on cartilage degeneration in OA.

In general, the paper is well written and flows well. I have but a few comments:

1. Keywords- The format of all keywords should be further unified.

2. Introduction- In addition to MRI and SR-PCI, are there any other common techniques used to conduct imaging studies of articular cartilage? Perhaps the authors can supplement the research status of this part in the introduction.

3. Figure 2- Can the authors add corresponding scalebars to each panel in Figure 2?

4. Figure 3- The background of Figure 3H should be consistent with other subgraph images.

5. Figure 5- Even if there is no statistical significance, it is suggested that the author should also give the corresponding P value to facilitate readers' better understanding.

6. The author mentions in the discussion that histological preparations might be a good gold standard, but they also have a measurement error due to processing, which may cause shrinkage due to specimen dehydration or other structural changes that occur during embedding, sectioning, and staining of the tissues. Since histology is the gold standard, should the authors consider including histological results for comparison with SR-PCI and MRI results?

Reviewer #2: The aim of this manuscript is to compare two imaging methods for cartilage thickness measurement, MRI and synchrotron radiation phase-contrast imaging. The topic is up-to-date as since many years the OA community has been searching for reliable (imaging) biomarkers that would be helpful in disease diagnosis and treatment monitoring. Cartilage thickness has been identified as a potential candidate for a reliable OA biomarker; therefore, it is important to investigate on its properties, specificity and sensitivity. Present study tries to address some of the pitfalls of cartilage thickness measurement from MRI images.

Unfortunately, the results of this study does not provide any considerable answers to the research questions, mostly because of an unfortunate study design. Manuscript contains substantial methodological flaws, which need to be addressed before publication.

1. The MRI part is referred to as “clinical” throughout the manuscript. As the ex-vivo cartilage samples have been examined, the expression “clinical” should be omitted. Using a clinical scanner with the clinical protocol is not sufficient to label this study as clinical.

2. The choice of SR-PCI as a counter-method for MRI is unclear. Authors even admitted that it could not serve as a gold standard measurement of cartilage thickness. Moreover, it is not mentioned in the manuscript how the slices were matched. What is the slice thickness of SR-PCI images? SR-PCI, despite superior resolution compared to MRI, is also just an approximation of the cartilage thickness measurement. Even on histological slices, it is hard to define the cartilage thickness mostly due to ragged bone-cartilage interface. Any other imaging modality with the lower resolution suffers from inaccuracies in thickness measurement simply because the resolution does not allow seeing those details.

3. That being said, the title “The Clinical MRI overestimates articular cartilage thickness and volume compared to synchrotron radiation phase-contrast imaging” is misleading, as it implies that SR-PCI is a gold standard method.

4. Introduction, last paragraph: here, the research question should be clearly stated. Was it the comparison between two modalities. Or was it a feasibility study for SR-PCI? Please omit the sentences discussing the results: “While both imaging modalities revealed significant differences..”, “These results suggest a specific means to improve..”.

5. Conclusion: Currently it is a compilation of the general statements. Please state the main finding(s) of your study here.

6. Another serious issue is the MRI protocol, which is far away from state-of-the art of the protocol for volumetric cartilage analysis (including the thickness measurement). The “OA Research Society International recommendation” to use T1-3D-GRE applies to focal cartilage defect detection, rather than volumetric analysis. On the contrary, the contrast of this sequence is very bad for volumetry analysis due to low contrast between cartilage and a surrounding tissue (bone, fluid effusion, fat) – it is obvious also on the Figure 2 (C). Isotropic 3D-DESS is currently a sequence of choice for any volumetric measurements. Using T1-3D-GRE penalizes the MRI part of this study to a large extent.

7. It is also recommended to investigate the influence of different available cartilage thickness measurement algorithms (nearest neighbor, surface normal, local thickness, field lines, etc), as they may provide different results for different imaging modalities.

8. In the results section, it is surprising that the MRI-thickness SD is lower compared to SR-PCI (6.8% vs 10% in non-OA and 9.8% vs 14.8%). Is that a mean +/- SD over 4 samples per group? Or is that a mean value through the slices? Either way, considering the superior image resolution of SR-PCI, one would expect much lower SD for SR-PCI measurements. In principle, the cartilage thickness measured here from MRI images includes 3 to 4 pixels from cartilage surface to the bone, at given resolution the accuracy is expected to be rather low.

9. Please add a representative cartilage segmentation in high detail for both modalities

10. To be able to discriminate between the accuracies of thickness measurement of these two methods (without having a ground truth), it is recommended to perform test-retest scans (including removing the specimen from the scanner) and inter-reader variability for the semi-automated segmentation.

11. Maybe a subject for a discussion: looking at the Fig 4 and Fig 5, these results suggest that using volume a primary endpoint for the OA detection is much better than using cartilage thickness.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Zhentian Wang

10 Aug 2023

PONE-D-22-34378R1MRI overestimates articular cartilage thickness and volume compared to synchrotron radiation phase-contrast imagingPLOS ONE

Dear Dr. Eames,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 24 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Zhentian Wang, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I think authors have revised the manuscript with my comments. The current manuscript has more related information and the mistakes have been solved. I therefore agreed this manuscript can be accepted for publication.

Reviewer #2: The authors' effort put in improving the manuscript is appreciated. Most of the comments have been addressed.

However, there are still couple of remaining issues concerning favoring FLASH over DESS sequence.

1. The first issue is the DESS contrast in Supplemental Figure 1. That does not resemble the contrast of properly optimized DESS. See below the example of the clinical DESS implementation.

Here is the example of a clinical DESS contrast: https://imgtr.ee/image/DESS-clinical.Wb7Fo you see it is substantially different to what is presented in SFig. 1. This should be addressed.

The second issue is the different resolution of DESS and FLASH - why is that? Both sequences should be set up in the same way.

Moreover, after adding the SFig.1, it seems that the FLASH image in the SFig.1 is visually different to the FLASH image in Fig. 2. Please clarify which contrast has been used. If that in the Fig. 2, it certainly disqualifies MRI.

These issues can falsely lead the readers to the thinking that DESS performs poorly in terms of segmentation as it has worse contrast and resolution than FLASH - and that is not correct.

Additionally, what is the speculation "This unexpected difference might be due to the dissected samples used, instead of larger samples or whole patient limbs." based on? Why would be the cartilage contrast be different between in-vivo and ex-vivo conditions?

2. Referring to the comment #7, I still believe that the different algorithm should be mentioned at least in the discussion as a limitation, as they might contribute to the thickness uncertainty quite a lot.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 2

Zhentian Wang

5 Sep 2023

MRI overestimates articular cartilage thickness and volume compared to synchrotron radiation phase-contrast imaging

PONE-D-22-34378R2

Dear Dr. Eames,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Zhentian Wang, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Zhentian Wang

25 Sep 2023

PONE-D-22-34378R2

MRI overestimates articular cartilage thickness and volume compared to synchrotron radiation phase-contrast imaging

Dear Dr. Eames:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Zhentian Wang

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Pilot comparison of MRI sequences suggested that FLASH gave more consistent contrast at cartilage boundaries than DESS.

    (A, B) Virtual slices of similar regions of the same sample from 3D reconstructed MRI datasets using either FLASH (A) or DESS (B) imaging sequences suggested that contrast between the cartilage and overlying fluid and subchondral bone was more consistent with FLASH. Scale bars: A,B = 0.5cm.

    (EPS)

    S2 Fig. A histological stain of a sectioned sample shows a similar cartilage thickness as calculated from 3D reconstructed image analyses.

    A tissue section of a non-OA sample was stained with Safranin O, independently confirming the presence of cartilage, meanwhile providing independent support for the measures of cartilage thickness obtained from the segmented cartilage on virtual slices. Scale bar = 0.4cm.

    (EPS)

    Attachment

    Submitted filename: Bairagi.etal.ResponsetoReviews.docx

    Attachment

    Submitted filename: Bairagi.etal.2ndResponsetoReviews.docx

    Data Availability Statement

    In order that others may replicate or extend our study findings, raw image files from all samples can be found at https://globus.usask.ca/file-manager?origin_id=ef36db6f-8e10-4b8b-93b5-ec8e895a7511&origin_path=%2F.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES